Kerri Millar
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kerri Millar
Kerri Millar is recorded as CFO at Cue Biopharma, Inc. (CUE). The proxy statement of Cue Biopharma, Inc. reports total compensation of $1,056,924 for Kerri Millar in fiscal 2022, including a base salary of $418,459. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cue Biopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel R. Passeri CEO, Board Member
- Dr. Shao-Lee Lin CEO, Board Member
- Lucinda Warren CEO, CFO
- Usman Azam CEO, Board Member
- James Ahlers CFO
- Colin G. Sandercock General Counsel
- Sumita Ray General Counsel
- Michael Meluzio Chief Accounting Officer
- Daniel Camardo Board Member
- Jill Broadfoot Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Cue Biopharma, Inc. (CUE) | Chief Financial Officer | $418,459 | $1,056,924 |
| 2021 | Cue Biopharma, Inc. (CUE) | Chief Financial Officer | $374,231 | $1,358,011 |
Recent activity
No call appearances or filed executive changes recorded yet.